Clinical Trial: A Study on the Association between Gut Microbiota Dysbiosis, Intestinal Barrier Function and Intestinal Metabolites in Patients with Vascular-Metabolic Ejection Fraction-Preserved Heart Failure, and Their Clinical Phenotypes and Short- to Medium-Term Prognosis (China)

China, Oct. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on the Association between Gut Microbiota Dysbiosis, Intestinal Barrier Function and Intestinal Metabolites in Patients with Vascular-Metabolic Ejection Fraction-Preserved Heart Failure, and Their Clinical Phenotypes and Short- to Medium-Term Prognosis'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133920

Registration Time: 2026/10/09

Type: Observational study

Primary Sponsor: The first hospital of Shanxi Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=346592

Published by HT Digital Content Services with permission from Heal...